Key Highlights: Implications: Triple Hair is turning TH07 into a genuinely global late‑stage asset in male pattern hair loss by running synchronized Phase III trials in Canada and In...
Key Highlights: Implications: Zintrodiazine’s Phase III go‑ahead positions Zydus as a front‑line Indian innovator in a space long dominated by global public–privat...
